KBC Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34.5M Buy
97,056
+54,204
+126% +$17.4M 0.07% 225
2026
Q2
$20.7M Buy
42,852
+26,206
+157% +$6.95M 0.04% 278
2026
Q1
$1.82M Buy
16,646
+1,030
+7% +$147K ﹤0.01% 667
2025
Q4
$2.6M Buy
15,616
+11,934
+324% +$2M 0.01% 567
2025
Q3
$721K Buy
3,682
+174
+5% +$28.6K ﹤0.01% 687
2025
Q2
$317K Buy
+3,508
New +$277K ﹤0.01% 753
2025
Q1
– Sell
-1,504
Closed -$199K – 1896
2024
Q4
$199K Buy
+1,504
New +$141K ﹤0.01% 1129

Other funds holding ALAB

KBC Group's ALAB Position: Q3 2026 in Review

KBC Group increased its Astera Labs (ALAB) stake by 126% in Q3 2026, buying an estimated $17.4M and bringing the position to 97,056 shares worth $34.5M. The position accounts for 0.07% of the portfolio, ranked #225.

KBC Group first reported a position in ALAB in Q4 2024 and has held it in 7 quarters since. 314 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • KBC Group held 97,056 shares of Astera Labs worth $34.5M as of Q3 2026.
  • KBC Group bought 54,204 Astera Labs shares in Q3 2026, an estimated $17.4M.
  • Astera Labs made up 0.07% of KBC Group's portfolio in Q3 2026, its #225 holding.
  • KBC Group first reported a position in Astera Labs in Q4 2024 and has held it in 7 quarters since.
  • 314 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.